Efficacy of infliximab (Remicade®) in the treatment of spondyloarthropathies. Two case reports [1]

Joint Bone Spine

Volumn 68, Issue 6, 2001, Pages 525-527

  Kaiser, M J ^a   Sany, J ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GOLD; INFLIXIMAB; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ADULT; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; LETTER; SIDE EFFECT; SPONDYLOARTHROPATHY; SYMPTOMATOLOGY;

EID: 0035671252     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(01)00320-7     Document Type: Letter

References (8)

1. Effects of loading regimen of three infusions of chimeric monoclonal antibody to tumor necrosis factor (infliximab) in spondylarthropathy: An open pilot study
2. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor a monoclonal antibody infliximab
3. Anti-TNF-α: A new dimension in the pharmacotherapy of the spondylarthropathies
4. Successful treatment of severe psoriatic arthritis with infliximab
5. A clinical and MRI assessment of the efficacy of the recombinant TNF alpha receptor: Fc fusion protein etanercept in the treatment of resistant spondylarthropathy
6. One year outcome of patients with severe psoriatic arthritis treated with infliximab
7. Crohn's disease with spondylarthropathy: Effect of tumor necrosis factor α blockade with infliximab on the articular symptoms
8. Randomized trial of etanercept (Enbrel®) in the treatment of psoriatic arthritis and psoriasis